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Case Presentation: 
A 28-year-old single African-American woman presented to the dental emergency clinic 
at the Creighton University School of Dentistry, Omaha, Nebraska, with a chief 
complaint of painful ulcerations of the oral cavity. The lesions had been present for at 
least several weeks and apparently had been slowly increasing in severity over this 
period. The patient had previously presented to a walk-in medical clinic for evaluation 
and was initially prescribed amoxicillin. When no clinical improvement was noted, she 
was switched to Augmentin (amoxicillin and clavulanate), prescribed nystatin troches 
and chlorhexidine rinses and advised to see a dentist.   
 
On initial presentation, the patient presented with multiple large crater-like erosions 
involving the palatal attached mucosa (figure 1a). The erosions were largely devoid of 
fibrin coating, except immediately along the border with the adjacent unaffected mucosa. 
In focal areas along the lateral margins of the erosions, an erythematous, raised, 
somewhat granular presentation was noted that resembled immature granulation tissue. 
The maxillary anterior attached gingiva had a somewhat granular appearance with linear 
ulcerations between the central incisors and interproximally between the left maxillary 
central and lateral incisors (figure 1b). The interdental papilla had a “punched out” 
necrotic appearance, but lacked a fetid odor. The palatal lesions were moderately painful 
to palpation. The patient denied having any similar vaginal or rectal lesions. The patient 
also reported that she had recently started to experience small pruritic erythematous skin 
lesions involving her arms (figure 2), legs and chest. Application of lateral pressure to the 
skin or oral mucosa failed to elicit a positive Nikolsky sign. No ocular or nail changes 
were noted.  
 
The patient was somewhat concerned that the lesions in her mouth might be related to a 
sexually transmitted condition and volunteered that she had recently undergone screening 
for syphilis, gonorrhea, Chlamydia and HIV through a community clinic to rule out this 
possibility. The patient did report an infection with gonorrhea several years earlier that 
had been successfully treated. The remainder of her past medical history was 
unremarkable. The patient did not report dyspnea, cough, nausea or abnormal bowel 




Based on the several week history of multiple shallow erosions involving primarily the 
hard palate and the maxillary anterior facial attached gingiva in a young patient with a 
relatively uncomplicated medical history, the focus of our clinical differential diagnosis 
revolved around the most common causes of chronic erosive lesions in the oral cavity; 
namely immune-mediated conditions, systemic granulomatous processes and chronic 
infectious conditions. We were, of course, concerned about our patient’s skin lesions and 
her history of mild malaise. However, it was not clear from her initial presentation 
whether the skin manifestations were a component of the disease process itself or were 
indicative of an allergic reaction to the amoxicillin. The history of mild generalized 
fatigue and malaise, while raising the possibility of hematological or systemic infectious 
processes, were, based on the patient’s self-reported history, mild and non-specific and 
had apparently not increased in severity or otherwise changed over the preceding several 
weeks.  
 
Our leading consideration was that this represented a chronic immune-mediated bullous 
disease. Pemphigoid, pemphigus, paraneoplastic pemphigus, linear IgA dermatosis, 
epidermolysis bullosa acquisita and chronic ulcerative stomatitis comprise a group of 
chronic conditions characterized by the production of auto-antibodies against various 
components of the epithelial/connective tissue attachment complex. These conditions 
affect the oral mucosa and/or skin and typically present with overlapping clinical 
presentations that often makes differentiation from each other based on clinical grounds 
alone difficult, particularly early in the disease process. Histopathological examination of 
both conventional formalin-fixed, paraffin-embedded hematoxylin and eosin (H&E) 
stained tissue and tissue preserved in Michel’s solution for immunofluorescent studies is 
usually necessary to arrive at a definitive diagnosis. Nevertheless, there are classical 
clinical differences between these conditions that warrant reviewing.  
 
Mucous membrane pemphigoid is an immune-mediated mucocutaneous condition 
characterized by the presence of autoantibodies directed against various components of 
the basement membrane zonei. In addition to the oral erosions, other mucosal sites 
including the nasal, vaginal, laryngeal and esophageal mucosa can be affected. Intact 
bullae are occasionally identified intra-orally. While the oral lesions typically heal 
without significant scarring, esophageal involvement can rarely lead to airway 
obstruction. More commonly, involvement of the ocular conjunctivae can lead to 
adhesions between the palpebral and bulbar conjunctivae and severe scarring. Skin 
lesions are uncommon. 
 
Pemphigus vulgaris, resulting from the production of antibodies directed against protein 
components of the desmosomal attachment, desmoglein 1 and 3, is seen with much less 
frequency than pemphigoidii. Oral lesions of pemphigus vulgaris, consisting of superficial 
erosions and ulcers that are distributed throughout the oral cavity but demonstrating 
preferential involvement of the palatal and labial mucosa, often precede the development 
of skin bullae by several months.  Intact bullae are rarely noted intraorally. Ocular lesions 
may be seen, but these typically are not associated with the same degree of scarring noted 
in pemphigoid. A variant of pemphigus vulgaris, pemphigus vegetans, is characterized by 
the development of vegetative erosionsiii, somewhat reminiscent of the exophytic areas 
noted at the periphery of several of the ulcerative lesions in our patient. Typically, 
however, the vermilion borders of the lips are involved preferentially.  
 
Paraneoplastic pemphigus is a very rare variant of pemphigus that occurs in association 
with an underlying neoplasm, particularly non-Hodgkin’s lymphomas, chronic 
lymphocytic leukemias and thymomasiv. The pathogenesis is poorly understood, although 
a percentage of cases may be related to tumor-associated overproduction of interleukin-6 
leading to the upregulation of anti-desmosomal antibody production. The clinical 
presentation is quite variable, ranging from classic pemphigus-like lesions, to 
pemphigoid-like ocular involvement to an erythema multiforme-like presentation with 
hemorrhagic crusting of the lips. In light of the patient’s chronic low-grade malaise, this 
was a reasonable possibility, although still considered unlikely due to the rarity of this 
condition and the lack of an identified underlying neoplasm. 
 
Several medications are known to cause either pemphigusv or pemphigoid-likevi eruptions 
(e.g. angiotensin-converting enzyme inhibitors, penicillamine) as well as non-specific 
ulcerations, also referred to as “stomatitis medicamentosa” (e.g. hydroxyurea, nicorandil, 
indomethacin, methotrexate). Obviously, review of the patient’s medical history would 
identify potential offending drugs, none of which were indicated in our patient. 
 
Linear IgA dermatosis (linear IgA disease; linear IgA bullous dermatosis of childhood), 
epidermolysis bullosa acquisita and chronic ulcerative stomatitis are rare cause of chronic 
erosive lesions of the oral cavity. Linear IgA dermatosis affects both children and adults 
and primarily involves the dermisvii. It is characterized by the development of large clear 
to hemorrhagic bullae occurring on normal or erythematous skin. In contrast to mucous 
membrane pemphigoid, oral lesions in the absence of extensive skin involvement are 
uncommon in linear IgA dermatosis. Epidermolysis bullosa acquisita is a chronic 
autoimmune blistering disease of the skin that in some cases can present with 
predominant mucosal involvement that is often clinically indistinguishable from mucous 
membrane pemphigoidviii. Chronic ulcerative stomatitis (CUS) is another rare immune-
mediated erosive condition that primarily affects the tongue, buccal mucosa and 
gingivaix. The clinical presentation of CUS is highly variable. Specialized 
immunofluorescent studies are typically necessary to differentiate between these 
conditions. 
 
Erythema multiforme is typically a self-limiting acute process characterized by the abrupt 
onset of rapidly progressing erosions of the lip, tongue, gingiva and lip mucosa coupled 
with erythematous skin macules that form “target-like” lesionsx. The oral lesions 
typically start as small vesicles that quickly rupture, leaving a raw ulcerated 
pseudomembranous surface. Viral-like prodromal symptoms ranging from generalized 
malaise to fever and cough are often noted. In approximately half of the cases, no 
precipitating factor is identified. In the remaining cases, common triggers include 
recurrent herpes activation and drugs such as antibiotics and non-steroidal anti-
inflammatory drugs. Typically, the lesions will resolve in 2-3 weeks, although recurrent 
episodes may be seen, especially in those cases related to herpes virus reactivation.  
 
Hematological conditions such as agranulocytosis, aplastic anemia and acute leukemia 
can cause generalized erosions of the oral cavity, but their onset tends to be more acute 
and fulminant compared to the relatively prolonged history in our patient’s case. 
 
While the possibility that these lesions represented major aphthous ulceration was briefly 
considered, the clinical presentation was not typicalxi. Classically, in the 
immunocompetent patient, major aphthae develop on the unattached gingiva, primarily 
involving the soft palate/tonsillar pillae or floor of the mouth. A well-defined, thin 
erythematous border is typically present, and the degree of pain is usually extreme. While 
atypical aphthous-like ulcerations are relatively common in patients with acquired 
immunodeficiency syndrome (AIDS), our patient insisted that she was HIV negative. In 
addition, the clinical appearance of the anterior maxillary attached gingiva was not 
compatible with major aphthae, having a slightly granular appearance. 
 
This granular presentation on the maxillary buccal gingiva raised the possibility of an 
underlying granulomatous process, most likely systemic considering the widespread 
involvement. Chronic granulomatous disease, a rare congenital condition associated with 
functional defects of phagocytes characterized by recurrent episodes of bacterial and 
fungal infections that are often life-threatening, was not seriously considered in our 
differential diagnosis because it typically manifests within the first few years of life.  
Wegener’s granulomatosis is an uncommon chronic condition of unknown etiology 
characterized by the development of necrotizing granulomatous inflammation that affects 
the upper and lower respiratory tract, as well as vasculitis of the small to medium 
diameter blood vessels. Patients typically present with non-specific constitutional 
symptoms, chronic sinonasal involvement and various cutaneous manifestations. Oral 
involvement is rarexii. The characteristic intraoral appearance, consisting of a bumpy, 
granular, hemorrhagic mucosal surface primarily affecting the buccal gingival surface, is 
termed “strawberry gingivitis.” In more advanced cases, irregular erosions and ulcers 
resembling the palatal lesions seen in our patient may be noted, potentially affecting any 
mucosal surface. 
 
Acute infectious processes such as primary herpetic gingivostomatitis could be ruled out 
based on the prolonged duration of the lesions. The possibility of AIDS-associated 
atypical ulcerations associated with recurrent herpes should be included in the differential 
diagnosis, even in light of the patient’s purported, but unconfirmed, HIV-negative status. 
 
Another consideration was that the oral and skin lesions represented mucocutaneous 
manifestations of secondary syphilis. However, the “mucous patches” of secondary 
syphilis present more typically as multiple edematous irregular appearing white thickened 
plaques, although epithelial necrosis of these plaques may lead to the formation of 
sizeable ulcersxiii. Non-specific constitutional symptoms such as malaise and weight loss 
are common. Diffuse erythematous skin rashes are a consistent presentation, but these are 
typically larger than the lesions noted in our patient. The patient’s claim that she had 
recently tested negative for a number of sexually transmitted diseases, including syphilis, 
should rule this out. 
 
Tuberculosis affecting the oral cavity is extremely rarexiv. Presumably oral lesions 
develop via inoculation from coughed up pulmonary organisms or following 
hematogenous spread. Oral lesions present as large ulcer with a central 
vegetative/granulomatous appearance with a slightly indurated border. Cervical 
lymphadenopathy is common. Multiple lesions, as noted in this case, would be extremely 
uncommon absent disseminated extrapulmonary disease in a severely 
immunocompromised patient.  
 
Although uncommon, invasive systemic mycoses such as mucormycosis, aspergillosis, 
histoplasmosis, cryptococcus, and North American blastomycosis can present with a 
clinical appearance similar to that seen in our patient. Typically, these are associated with 
some type of underlying condition leading to a weakened immune response. 
 
Finally, the presence of the blunted interproximal papillae seen in our patient could raise 
the consideration of necrotizing ulcerative gingivitis (NUG), an acute condition 
characterized by spirochete-mediated destruction of the interdental papillae resulting in a 
“punched out” appearance. However, the prolonged duration and the presence of large 
palatal erosions are not consistent with NUG. 
 
Diagnosis and Management: 
An incisional biopsy was obtained from the attached palatal mucosa under local 
anesthesia, and the tissue placed in formalin and submitted for hematoxylin and eosin 
staining. Although we were suspicious of an immune-mediated vesiculobullous process, 
we elected not to obtain additional tissue for direct immunofluorescence at this stage 
since our differential diagnosis was quite broad. 
 
Histologic examination revealed oral mucosa surfaced by intact parakeratinized stratified 
squamous epithelium overlying variably dense fibrovascular connective tissue. A 
moderately dense mixed inflammatory cell infiltrate was noted within the deeper 
connective tissue along one of the edges of the specimen (figure 3a). On close 
examination of the H&E-stained specimen, faint round to ovoid intracytoplasmic bodies 
were noted within macrophages along one of the lateral aspects of the specimen (figure 
3b). These intracytoplasmic bodies were better visualized following periodic acid–Schiff 
(PAS; figure 3c) and Gomori methenamine silver (GMS; figure 3d) staining. These 
fungal organisms, measuring approximately 2–4 µm in diameter, consisting of a central 
round basophilic body surrounded by a clear staining halo under H&E staining, were 
consistent with Histoplasma spp. Definitive identification of H. capsulatum, either by 
testing of cultured tissue with a chemiluminescent DNA probe or serologic/urine enzyme 
immunoassay screening for Histoplasma polysaccharide antigen, was not performed. 
However, the histopathologic presentation was strongly suggestive of Histoplasma 
capsulatum. 
 
The final diagnosis was intrahistiocytic fungal infection consistent with histoplasmosis. 
 
Several attempts were made to contact the patient by telephone in order to refer her to a 
local infectious disease clinic. Eventually, a family member volunteered that the patient 
had been admitted to a neighboring hospital the day after her biopsy had been performed 




Histoplasmosis is a systemic invasive fungal disease endemic to the parts of the Midwest 
of the United States, in particular around the Mississippi and Ohio Valley, as well as in 
parts of the Central and Southeast states. In the Americas, histoplamosis is caused by the 
dimorphic yeast histoplasma capsulatum var. capsulatum, which grows in nitrogen-rich 
soil as well as in areas contaminated with bird and bat feces. At 37 degrees Celsius, the 
mold converts to a 2 to 4 um oval yeast form that is taken up by macrophages in the lung. 
An estimated 80% of the adult population in parts of the Midwest show immunologic 
evidence of prior exposure to the organism.  
 
Histoplasma exposure can result in acute or chronic forms of histoplasmosis. Primary 
acute pulmonary histoplasmosis is a self-limiting form that infects up to 500,000 people 
per year in the United States. The vast majority of infected people are not even aware 
they have been infected, especially when the individual has been exposed to only small 
numbers of sporesxv. When exposed to very high numbers of spores, individuals are more 
likely to develop acute pulmonary histoplasmosis, manifesting as non-specific pulmonary 
symptoms such as cough, and dyspnea as well as constitutional symptoms ranging from 
low-grade fever to malaise that are often misinterpreted as a routine upper respiratory 
tract infection. In the immunocompetent host, this is usually self-limiting and often does 
not require treatment.  
 
Individuals at the greatest risk of developing chronic histoplasma infection include those 
with suppressed immune systems and/or underlying chronic lung disease. Chronic 
pulmonary infection is associated with the development of pulmonary cavitations and is 
characterized by pulmonary signs and symptoms reminiscent of tuberculosis. This 
presentation is primarily seen in patients with chronic obstructive lung disease. If 
untreated, the long-term outcome invariably involves progressive pulmonary 
insufficiency and death. There is also a rare disseminated form in which spores spread to 
the lymph nodes, bone marrow, liver, spleen, adrenal glands and gastrointestinal tract, 
resulting in widespread symptoms of systemic infection, lymphadenopathy, 
hepatosplenomegaly and other extrapulmonary manifestations.  
 
The vast majority of cases of oral histoplasmosis are associated with the disseminated 
form of the diseasexvi. The most common oral sites of involvement include the tongue, 
palate, gingiva and buccal mucosaxvii. Oral lesions classically have an irregular ulcerated 
appearance with a granular exophytic margin and rolled indurated borders resembling 
squamous cell carcinomaxviii. Erosion of underlying bone may be seen. However, the 
clinical presentation is highly variable. Multiple lesions, as in our case, are uncommon. 
Facial skin lesions, occasionally resembling the skin papules associated with molluscum 
contagiosum, may also be present. 
 
The disseminated form of histoplasmosis, the underlying type seen in patients presenting 
with oral manifestations, is usually seen only in immunocompromised patients, either 
secondary to AIDS (especially with CD4 counts of less than 150 cells/um), 
immunosuppressive therapy or severe debilitation/advanced age. Prior to the AIDS 
epidemic, disseminated histoplasmosis was extremely rare. Since the introduction of 
effective anti-retroviral drugs, this has once again become less common. Patients treated 
with biologic agents that target tumor necrosis factor-alpha, such as infliximab 
(Remicade; Centocor, Malvern, PA), adalimumab (Humira; Abbott Laboratories, Abbot 
Park, IL) and etanercept (Enbrel; Amgen Corp., Thousand Oaks, CA), also appear to be 
at a substantially increased risk of developing invasive fungal infections, particularly 
histoplasmosisxix,xx. To date, the majority of these cases have occurred among patients 
living in areas endemic for histoplasmosis who were also receiving additional 
immunosuppressant therapy. In one studyxx, the death rate in patients developing 
disseminated fungal infection following tumor necrosis factor-alpha blockade therapy 
approached 20%.  
 
Our patient denied a history of AIDS or immunosuppressive therapy, although without 
direct testing, her HIV status and CD4 count could not be definitely determined. 
Interestingly, it has been demonstratedxxi in a murine model that methamphetamine abuse 
reduces the immune response to histoplasma infection through several mechanisms. 
Methamphetamine use is widespread in parts of the Midwest of the United States, 
including Nebraskaxxii. Since we never asked our patient specifically about any history of 
drug abuse, we can only speculate in retrospect as to whether methamphetamine abuse 
might have been a contributing factor in this case. 
 
Treatment of disseminated histoplasmosis involves management of any underlying 
disease process, such as antiretroviral therapy to increase the CD4 count in AIDS, 
combined with long-term systemic antifungal therapy. The recommended therapy for 
mild to moderately severe disseminated histoplasmosis is 200mg oral itraconazole twice 
daily for 6 to 18 months, depending on response to therapy and underlying host 
resistancexv. In cases of severe disseminated histoplasmosis, an initial short course with 
amphotericin B, switching to itraconazole as the patient’s condition improves, is 
suggested. Long term prophylaxis with itraconazole, 200mg per day, should be 
considered in AIDS patients with CD4 counts below 150 to 200 cells/um.  
Captions to Figures: 
Figure 1a:  
A 28-year-old woman presented with a several week history of large painful erosions 
involving the palatal attached mucosa. The erosions are largely devoid of fibrin coating. 
Along the lateral margins of the erosions, a somewhat granular appearance resembling 
granulation tissue is noted.  
 
Figure 1b: 
The maxillary anterior attached gingiva exhibits a granular appearance with linear 
ulcerations noted interproximally between the central incisors and between the left 




The patient recently started to experience small pruritic erythematous skin lesions 
involving her arms, legs and chest. A closeup of the skin lesions on her arm is shown. 
 
Figure 3a: 
Histologic examination reveals oral mucosa covered by intact epithelium containing a 
moderately dense mixed inflammatory cell infiltrate along the lower edge of the 
specimen (hematoxylin and eosin, original magnification 40x). 
 
Figure 3b: 
On higher magnification, numerous faint round to ovoid intracytoplasmic bodies 
consisting of a central round basophilic body surrounded by a clear staining halo can be 
visualized within macrophages (hematoxylin and eosin, original magnification 200x). 
 
Figure 3c:  
These fungal organisms, measuring approximately 2–4 µm in diameter, are better 
visualized following periodic acid–Schiff (PAS) staining (original magnification 200x). 
 
Figure 3d:  




                                                
i Scully C, LoMuzio L. Oral mucosal diseases: mucous membrane pemphigoid. Brit J 
Oral Maxillofac Surg 2008;46:358-66. 
ii Scully C, Mignogna M. Oral mucosal diseases: pemphigus. Brit J Oral Maxillofac Surg 
2008;46:272-7. 
iii Markopoulos AK, Antoniades DZ, Zaraboukas T. Pemphigus vegetans of the oral 
cavity. Int J Dermatol 2006;45:425-8.  
iv Zhu X, Zhang B. Paraneoplastic pemphigus. J Dermatol 2007;43:503-11. 
v Brenner S, Bialy-Golan A, Ruocco V. Drug-induced pemphigus. Clin Dermatol 
1998;16:393-7. 
vi Vassileva S. Drug-induced pemphigoid: bullous and cicatricial. Clin Dermatol 
1992;16:379-87. 
vii Lewis MA, Yaqoob NA, Emanuel C, Potts AJ. Successful treatment of oral linear IgA 
disease using mycophenolate. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 
2007;103:483-6. 
viii Lehman JS, Camilleri MJ, Gibson LE. Epidermolysis bullosa acquisita: concise review 
and practical considerations. Int J Dermatol 2009;48:227-36. 
ix Solomon LW, Aguirre A, Neiders M, Costales-Spindler A, Jividen Jr GJ, Zwick MJ, 
Kumar V. Chronic ulcerative stomatitis: Clinical, histopathologic, and immunopathologic 
findings. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2003;96:718-26. 
x Al-Johani KS, Fedele S, Porter SR. Erythema multiforme and related disorders. Oral 
Surg Oral Med Oral Pathol Oral Radiol Endod 2007;103:642-54. 
                                                                                                                                            
xi Jurge S, Kuffer R, Scully C, Porter SR. Mucosal diseases series number VI: recurrent 
aphthous stomatitis. Oral Diseases 2006;12:1-21. 
xii Hernandez G, Serrano C, Porras L, Lopez-Pintor R, Rubio L, Yanes J. Strawberry-like 
gingival tumor as the first sign of Wegener’s granulomatosis. J Periodontol 
2008;79:1297-1303. 
xiii Little JW. Syphilis: an update. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 
2005;100:3-9. 
xiv Hale RG, Tucker DI. Head and neck manifestations of tuberculosis. Oral Maxillofac 
Surg Clin North Am 2008;20:635-42. 
xv Kauffman CA. Histoplasmosis: a clinical and laboratory update. Clin Micrbiol Rev 
2007;20:115-32. 
xvi Chinn H, Chernoff DN, Migliorati CA, Silverman Jr S, Green TL. Oral histoplasmosis 
in HIV-infected patients: a report of two cases. Oral Surg Oral Med Oral Pathol Oral 
Radiol Endod 1995;79:10-4. 
xvii Bhagwat PV, Hanumanthayya K, Tophakhane RS, Rathod RM. Two unusual cases of 
histoplasmosis in human immunodeficiency virus-infected individuals. Indian  Dermatol 
Venereol Leprol 2009;75:173-6. 
xviii Narayana N, Gifford R, Giannini P, Casey J. Oral histoplasmosis: an unusual 
presentation. Head Neck 2009;31:P274-7. 
xix Furst DE, Wallis R, Broder M, Beenhouwer DO. Tumor necrosis factor antagonists: 
different kinetics and/or mechanisms of action may explain differences in the risk for 
developing granulomatous infection. Semin Arthritis Rheum 2006;36:159-67.  
                                                                                                                                            
xx Tsiodras S, Samonis G, Boumpas DT, Kontoyiannis DP. Fungal infections 
complicating tumor necrosis factor alpha blockade therapy. Mayo Clin Proc 
2008;83:181-94. 
xxi Martinez LR, Mihu MR, Gacser A, Santambrogio L, Nosanchuk JD. 
Methamphetamine enhances histoplasmosis by immunosuppression of the host. J 
Infectious Diseases 2009;200:131-41. 
xxii Shaner JW, Kimmes N, Saini T, Edwards PC. Meth mouth: rampant caries in 
methamphetamine abusers. AIDS Patient Care and STDs 2006;20:4-8. 
